gettyKey FactsOxford University has begun searching for participants in the early-stage trial, the Financial Times reported Thursday, which will take around four months to complete and could begin as early as next week. Forbes has reached out to AstraZeneca and Oxford for comment. MailOnline has approached Oxford University and AstraZeneca for comment. Fox News' Alexandria Hein contributed to this report. Researchers hope the spray may be readily available in pharmacies in the coming months.
Forbes is not willing to lock people down for a study.
( z0 will :ARG0 ( z1 company :name ( z2 name :op "Forbes" ) ) :ARG1 ( z3 lock :purpose ( z4 study ) :ARG0 z1 :ARG1 ( z5 person ) :mod ( z6 down ) ) :polarity - )
(z0 / will-02
    :ARG0 (z1 / company
              :name (z2 / name
                        :op1 "Forbes"))
    :ARG1 (z3 / lock-01
              :purpose (z4 / study-01)
              :ARG0 z1
              :ARG1 (z5 / person)
              :mod (z6 / down))
    :polarity -)
Forbes is not willing to lock people down for a study .
z1 :name z2
z2 :op1 1
z0 :polarity 0
z0 :ARG0 z1
z0 :ARG1 z3
z3 :ARG0 z1
z3 :ARG1 z5
z3 :mod z6
z3 :purpose z4